Real-world effectiveness and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes and renal impairment: a subgroup analysis of the ATOS study

被引：0
|
作者：
Tirosh, A. [1 ,2 ]
Khan, N. [3 ]
Vargas-Uricoechea, H.
Mabunay, M. A. N. [4 ]
Coudert, M. [5 ]
Pilorget, V. [5 ]
Galstyan, G. [6 ]
机构：
[1] Chaim Sheba Med Ctr, Div Endocrinol Diabet & Metab, Tel Hashomer, Israel
[2] Tel Aviv Univ, Tel Hashomer, Israel
[3] Imperial Coll London, Diabet Ctr, Al Ain, U Arab Emirates
[4] Univ Cauca, Div Endocrinol & Metab, Dept Internal Med, Popayan Cauca, Colombia
[5] Sanofi, Singapore, Singapore
[6] Hlth Care Minist Russian Federat, Endocrinol Res Ctr, Moscow, Russia
来源：
DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
506
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [1] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study
    Galstyan, Gagik R.
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen
    Coudert, Mathieu
    Naqvi, Mubarak
    Pilorget, Valerie
    Khan, Niaz
    DIABETES THERAPY, 2022, 13 (06) : 1187 - 1202
  • [2] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND RENAL IMPAIRMENT: A SUBGROUP ANALYSIS OF ATOS STUDY
    Tirosh, A.
    Khan, N.
    Vargas-Uricoechea, H.
    Mabunay, M. A. N.
    Coudert, M.
    Pilorget, V.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A100 - A101
  • [3] Real-world effectiveness and safety of insulin glargine 300 U/ml in insulin-naive people with type 2 diabetes in the Latin America region: A subgroup analysis of the ATOS
    Vargas-Uricoechea, Hernando
    Burga Nunez, Jose Luis
    Rosas Guzman, Juan
    Silva-Gomez, Liliana
    Beltran, Sergio
    Sanudo-Maury, Maria Elena
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 238 - 247
  • [4] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Insulin-Naive People with Type 2 Diabetes (T2DM) and Renal Impairment (RI): A Subgroup Analysis of the ATOS Study
    Tirosh, Amir
    Khan, Niaz
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen N.
    Coudert, Mathieu
    Pilorget, Valerie
    Galstyan, Gagik R.
    DIABETES, 2021, 70
  • [5] REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): THE ATOS STUDY
    Galstyan, G.
    Tirosh, A.
    Vargas-Uricoechea, H.
    Mabunay, M.
    Quan, J.
    Pilorget, V.
    Cherkasov, D.
    Naqvi, M.
    Khan, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A23 - A23
  • [6] ATOS: REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES: AD-HOC ANALYSIS OF RUSSIAN POPULATION.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A98 - A99
  • [7] TITRATION PATTERNS OF INSULIN GLARGINE 300 U/ML IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND CLINICAL OUTCOMES: A SUBGROUP ANALYSIS OF ATOS STUDY
    Tirosh, A.
    Singh, A. K.
    Vargas-Uricoechea, H.
    Mabunay, M. A.
    Bigot, G.
    Naqvi, M.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A132 - A133
  • [8] Titration patterns of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes and clinical outcomes: a subgroup analysis of ATOS study
    Tirosh, A.
    Singh, A.
    Vargas-Uricoechea, H.
    Mabunay, M. A.
    Bigot, G.
    Naqvi, M.
    Galstyan, G.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S355 - S355
  • [9] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
    Gagik R. Galstyan
    Amir Tirosh
    Hernando Vargas-Uricoechea
    Maria Aileen Mabunay
    Mathieu Coudert
    Mubarak Naqvi
    Valerie Pilorget
    Niaz Khan
    Diabetes Therapy, 2022, 13 : 1187 - 1202
  • [10] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (gla-300) in Insulin-Naive Patients with Type 2 Diabetes (T2DM): Interim Analysis of the ATOS Study
    Galstyan, Gagik R.
    Bhansali, Anil
    Vargas-Uricoechea, Hernando
    Tirosh, Amir
    Sun, Guannan
    Naqvi, Mubarak
    Pilorget, Valerie
    Coudert, Mathieu
    Cherkasov, Dmitry
    Khan, Niaz
    DIABETES, 2020, 69
12345